Financing Cash Flow
Bristol-Myers Squibb Financing Cash Flow increased by 74.1% to -$1.56B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 57.1%, from -$993.00M to -$1.56B. Over 2 years (FY 2021 to FY 2025), Financing Cash Flow shows an upward trend with a -20.1% CAGR.
Analysis
How to read this metric
A large negative value typically indicates a company is returning capital to shareholders or paying down debt, while a positive value suggests the company is raising external capital to fund operations or acquisitions.
Detailed definition
This metric represents the net flow of cash between a company and its capital providers, including shareholders and lend...
Peer comparison
Large-cap peers like Microsoft or Alphabet similarly show large negative financing outflows due to aggressive share repurchase programs and dividend distributions.
net_cash_from_financingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$3.18B | -$1.78B | -$3.97B | -$5.65B | -$3.52B | -$4.54B | -$3.25B | -$3.05B | -$2.17B | -$5.16B | $14.64B | -$4.02B | -$3.85B | -$993.00M | -$1.84B | -$1.49B | -$6.03B | -$1.56B |
| QoQ Change | — | +44.1% | -122.9% | -42.5% | +37.7% | -29.1% | +28.5% | +6.0% | +28.8% | -137.5% | +383.8% | -127.5% | +4.3% | +74.2% | -84.9% | +18.8% | -304.6% | +74.1% |
| YoY Change | — | — | — | — | -10.6% | -155.2% | +18.2% | +46.0% | +38.3% | -13.6% | +580.1% | -85.1% | +25.3% | -106.8% | +54.4% | +61.3% | — | -57.1% |
Financing Cash Flow at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's financing cash flow?
- Bristol-Myers Squibb (BMY) reported financing cash flow of -$1.56B in Q1 2026.
- How has Bristol-Myers Squibb's financing cash flow changed year-over-year?
- Bristol-Myers Squibb's financing cash flow decreased by 57.1% year-over-year, from -$993.00M to -$1.56B.
- What is the long-term trend for Bristol-Myers Squibb's financing cash flow?
- Over 2 years (2021 to 2025), Bristol-Myers Squibb's financing cash flow has grown at a -20.1% compound annual growth rate (CAGR), from -$16.22B to -$10.35B.
- What does financing cash flow mean?
- The total amount of money a company spends or receives from borrowing debt and managing its own shares and dividends.